Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2499${count})

  • Translational Pipeline Program, 2023
    Using Sleep Modulation to Enhance the Brain’s Waste Clearance Mechanisms as an Approach to Limiting the Progression of Parkinson’s Disease

    Study Rationale: Recent studies have demonstrated that the brains of people with Parkinson’s disease (PD) show a buildup of toxic proteins that is due to an impairment in the brain’s waste clearance...

  • Research Grant, 2023
    Enhancing Access to Meaningful Data: Nebraska Parkinson’s Disease Registry

    Study Rationale: Nebraska’s Parkinson’s Disease Registry (NPDR) will roll out a new electronic data collection system, enforce state statutes requiring that physicians participate in reporting...

  • Translational Pipeline Program, 2023
    Exploring the Use of Molecules that Stabilize the Interaction between LRRK2 Kinase and the 14-3-3 Adapter Protein as a Neuroprotective Therapy for Parkinson’s Disease

    Study Rationale: Parkinson’s disease (PD) is associated with activating mutations in a protein kinase called LRRK2. In previous studies, we found that regulating LRRK2’s chemical modification by...

  • Parkinson’s Pathway Molecular Data Analysis Program, 2022
    Assessment of Proinflammatory Cytokines as Biomarkers for Parkinson’s Disease

    Study Rationale: We have generated a computer-based model that simulates alterations in molecular mechanisms associated with Parkinson’s disease (PD) genes. This model suggested that, in sporadic...

  • Parkinson’s Pathway Molecular Data Analysis Program, 2022
    Interaction of Mitochondrial Genes and Lifestyle Factors on Age at Onset in Parkinson’s Disease

    Study Rationale: Cellular structures called mitochondria are functionally impaired in Parkinson’s disease (PD). How environmental toxins or lifestyle factors influence mitochondrial function and...

  • Parkinson’s Pathway Molecular Data Analysis Program, 2022
    Developing Biomarker Signatures of Parkinson’s Disease Using a Novel Progression Model

    Study Rationale: Although Parkinson’s disease (PD) affects individuals differently, there are groups of people with PD who share similar features and whose disease changes similarly over time...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.